Delta Air Strains, Inc. DAL will launch its first-quarter monetary outcomes earlier than the opening bell on Wednesday, April 9.
Analysts count on the Atlanta, Georgia-based firm to report quarterly earnings at 39 cents per share, down from 45 cents per share within the year-ago interval. Delta Air Strains tasks quarterly income of $13.46 billion, in comparison with $13.75 billion a 12 months earlier, in keeping with knowledge from Benzinga Professional.
On March 10, Delta Air Strains reduce its first-quarter income and revenue steering.
Delta Air Strains shares fell 3.8% to shut at $35.88 on Tuesday.
Benzinga readers can entry the most recent analyst scores on the Analyst Inventory Scores web page. Readers can kind by inventory ticker, firm title, analyst agency, ranking change or different variables.
Let’s take a look at how Benzinga’s most-accurate analysts have rated the corporate within the current interval.
- Barclays analyst Brandon Oglenski maintained an Chubby ranking and reduce the value goal from $80 to $58 on April 8, 2025. This analyst has an accuracy fee of 60%.
- Susquehanna analyst Christopher Stathoulopoulos maintained a Optimistic ranking and slashed the value goal from $80 to $50 on April 7, 2025. This analyst has an accuracy fee of 70%.
- UBS analyst Thomas Wadewitz downgraded the inventory from Purchase to Impartial and lowered the value goal from $77 to $42 on April 7, 2025. This analyst has an accuracy fee of 69%.
- Raymond James analyst Savanthi Syth maintained a Sturdy Purchase ranking and reduce the value goal from $80 to $62 on April 2, 2025. This analyst has an accuracy fee of 64%.
- Jefferies analyst Sheila Kahyaoglu downgraded the inventory from Purchase to Maintain and decreased the value goal from $85 to $46 on April 1, 2025. This analyst has an accuracy fee of 69%.
Contemplating shopping for DAL inventory? Right here’s what analysts suppose:
Learn This Subsequent:
Photograph through Shutterstock
Market Information and Knowledge delivered to you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.